Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia

Journal of Cardiothoracic Surgery

Volumn 4, Issue 1, 2009, Pages

  Karapanagiotidis, Georgios T ^a   Antonitsis, Polychronis ^a   Charokopos, Nicholas ^a   Foroulis, Christophoros N ^a   Anastasiadis, Kyriakos ^a   Rouska, Efthymia ^a   Argiriadou, Helena ^a   Rammos, Kyriakos ^a   Papakonstantinou, Christos ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; STROMELYSIN;

ADULT; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; DISSECTING ANEURYSM; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDY; THORACIC AORTA ANEURYSM;

ADULT; AGED; ANEURYSM, DISSECTING; AORTIC ANEURYSM, THORACIC; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES;

EID: 71149090164     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-4-59     Document Type: Article

References (26)

1. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993, 4:197-250.
2. Galis ZS and Khatri JJ. Matrix metalloproteinases in vascular remodelling and atherogenesis: The good, the bad, and the ugly. Circulation Research 2002, 90:251-62.
3. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res 2003, 92:827-839. 10.1161/01.RES.0000070112.80711.3D, 12730128.
4. Isselbacher EM. Thoracic and abdominal aortic aneyrysms. Circulation 2005, 111:816-828. 10.1161/01.CIR.0000154569.08857.7A, 15710776.
5. Dollery CM, McEwan JR, Henney A. Matrix metalloproteinases and cardiovascular disease. Circ Res 1995, 7:863-8.
6. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrade activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994, 94:2493-503. 330083, 7989608, 10.1172/JCI117619.
7. Hojo Y, Ikeda U, Ueno S, Arakawa H, Shimada K. Expression of matrix metalloproteinases in patients with acute myocardial infarction. Jpn Circ J 2001, 65:71-75. 10.1253/jcj.65.71, 11216828.
8. Toshiharu I, Noriko A. Collagen and elastin degradation by matrix metalloproteinase in aortic dissection. Hum Pathol 2000, 31:640-646. 10.1053/hupa.2000.7642, 10872655.
9. Lijnen HR. Metalloproteinases in development and progression of vascular disease. Pathophysiol Haemost Thromb 2004, 33:275-281.
10. Woessner JF. Matrix metalloproteinases inhibition: from the Jurassic to the third millennium. Ann NY Acad Sci 1999, 878:388. 10.1111/j.1749-6632.1999.tb07697.x, 10415743.
11. Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem 1999, 274:21491-94. 10.1074/jbc.274.31.21491, 10419448.
12. Matrisian LM. The matrix degrading metalloproteinases. Bioessays 1992, 14:455-463. 10.1002/bies.950140705, 1445287.
13. Murphy G, Nagase H. Progress in matrix metalloproteinases research. Mol Asp Med 2008, 29:290-308.
14. Montero I, Orbe J, Varo N, Beloqui O, Monreal JI, Rodríguez JA, Díez J, Libby P, Páramo JA. C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. J Am Coll Cardiol 2006, 47:1369-78. 10.1016/j.jacc.2005.10.070, 16580524.
15. Orbe J, Fernandez L, Rodriguez JI, Rabago G. Different expressions of MMPs/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bed. Atherosclerosis 2003, 170:269-76. 10.1016/S0021-9150(03)00251-X, 14612207.
16. Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, Kuwahara F, Ueno T, Sugi K, Imaizumi T. Peripheral blood levels of matrix metalloproteinases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 1998, 32:368-72. 10.1016/S0735-1097(98)00250-2, 9708462.
17. Nambi V, Morrison A, Hoogeveen RC, Coresh J, Miles S, Rhodes CE, Sharrett AR, Boerwinkle BE, Ballantyne CM. Matrix metalloproteinase-1 and tissue inhibitors do not predict incident coronary artery disease. Tex Heart Inst J 2008, 35:388-94. 2607088, 19156230.
18. Mir MA. Aortic dissection - in pursuit of a serum marker. Am J Emerg Med 2008, 26:942-45. 10.1016/j.ajem.2007.12.012, 18926356.
19. Newman KM, Ogata Y, Malon AM, Irizarry E, Gandhi RH, Nagase H, Tilson MD. Identification of matrix metalloproteinases-3 and -9 in abdominal aneurysm. Arterioscler Thromb 1994, 14:1315-8.
20. Carrell TW, Burnard KG, Wells GM, Clements JM, Smith A. Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 2002, 105:477-82. 10.1161/hc0402.102621, 11815431.
21. Tengiz I, Ercan E, Aliyev E, Sekuri C, Duman C, Altuglu I. Elevated levels of matrix metalloproteinase-3 in patients with coronary aneurysm: A case control study. Cur Contr Tr Cardiovasc Med 2004, 5:1-10.
22. Keeling WB, Armstrong PA, Stone P, Bandyk DF, Shames ML. An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc Endovasc Surg 2005, 39:457-64.
23. Sangiorgi G, D'Averio R, Mauriello A, Bondio M, Pontillo M, Castelvecchio S, Trimarchi S, Tolva T, Nano G, Rampoldi V, Spagnoli LG, Inglese L. Plasma levels of metalloproteinases-3 and -9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment. Circulation 2001, 104(suppl 1):288-295.
24. Monaco M, Stassano P, DiTomasso L, Iannelli G. Response of plasma matrix metalloproteinases and tissue inhibitor of metalloproteinases to stent-graft surgery for descending thoracic aortic aneurysms. J Thorac Cardiovasc Surg 2007, 134:925-31. 10.1016/j.jtcvs.2007.05.044, 17903509.
25. Sangiorgi G, Trimarchi S, Mauriello A, Righini P, Bossone E, Suzuki T, Rampoldi V, Eagle KA. Plasma levels of metalloproteinases-9 and -2 in the acute and subacute phases of type A and type B aortic dissection. J Cardiovasc Med 2006, 7:307-315.
26. Joffs C, Gunasinghe HR, Multani MM, Dorman BH, Kratz JM, Crumbley AJ, Crawford FA, Spinale FG. Cardiopulmonary bypass induces the synthesis and release of matrix metalloproteinases. Ann Thorac Surg 2001, 71:1518-23. 10.1016/S0003-4975(01)02442-0, 11383793.